Clinical Development
How important is patient-centricity in rare disease studies?
Patient-centricity is becoming increasingly important in all areas, but particularly in rare diseases. In this post, Dr. Richard Scheyer discusses the importance of patient-centricity in…
Clinical Development
How to Leverage Research Networks to Accelerate Orphan Drug Development
In this post, Dr. Terence Eagleton highlights the growing interest in the development of products in the rare disease space, the unique challenges involved, and…